Michael Kishko

2.0k total citations
22 papers, 1.5k citations indexed

About

Michael Kishko is a scholar working on Infectious Diseases, Epidemiology and Animal Science and Zoology. According to data from OpenAlex, Michael Kishko has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 13 papers in Epidemiology and 5 papers in Animal Science and Zoology. Recurrent topics in Michael Kishko's work include Respiratory viral infections research (8 papers), Viral gastroenteritis research and epidemiology (6 papers) and Herpesvirus Infections and Treatments (5 papers). Michael Kishko is often cited by papers focused on Respiratory viral infections research (8 papers), Viral gastroenteritis research and epidemiology (6 papers) and Herpesvirus Infections and Treatments (5 papers). Michael Kishko collaborates with scholars based in United States, France and Netherlands. Michael Kishko's co-authors include Dan H. Barouch, Diana M. Truitt, Shawn M. Sumida, Michelle A. Lifton, Darci A. Gorgone, Norman L. Letvin, Janelle C. Arthur, Jaap Goudsmit, Menzo Havenga and Shawn S. Jackson and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Kishko

21 papers receiving 1.5k citations

Peers

Michael Kishko

GENET

MB

IMMUN

ID

EPIDE

Jason G. Gall United States

Natalie A. Hutnick United States

Eric A. Weaver United States

Marcio O. Lasaro United States

Drew L. Lichtenstein United States

Hanne Gahéry‐Ségard France

Andrea Maisner Germany

Angela Carville United States

Alasdair Maclean United Kingdom

Diana M. Lynch United States

Jason G. Gall United States

Michael Kishko

1.0k ×1.7

GENET

736 ×1.3

MB

382 ×0.7

IMMUN

527 ×1.0

ID

417 ×0.9

EPIDE

Citations per year, relative to Michael Kishko Michael Kishko (= 1×) peers Jason G. Gall

Countries citing papers authored by Michael Kishko

Since Specialization

Citations

This map shows the geographic impact of Michael Kishko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kishko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kishko more than expected).

Fields of papers citing papers by Michael Kishko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kishko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kishko. The network helps show where Michael Kishko may publish in the future.

Co-authorship network of co-authors of Michael Kishko

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kishko. A scholar is included among the top collaborators of Michael Kishko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kishko. Michael Kishko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Kishko, Michael, Yvonne Chan, De-An Huang, et al.. (2025). A Computationally Designed Prefusion Stabilized Human Metapneumovirus Fusion Protein Vaccine Antigen Elicited a Potent Neutralization Response. Vaccines. 13(5). 523–523.

2.

Kishko, Michael, Charles Pin‐Kuang Lai, Mark Parrington, et al.. (2024). Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein. PLoS ONE. 19(4). e0301773–e0301773. 4 indexed citations

3.

Berry, Catherine, Vincent Pavot, Natalie G. Anosova, et al.. (2023). Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters. SHILAP Revista de lepidopterología. 3(1). 75–75. 2 indexed citations

4.

Pavot, Vincent, Catherine Berry, Michael Kishko, et al.. (2023). Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates. Nature Communications. 14(1). 12 indexed citations

5.

Pavot, Vincent, Catherine Berry, Michael Kishko, et al.. (2022). Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates. Nature Communications. 13(1). 1699–1699. 25 indexed citations

6.

Pavot, Vincent, Michael Kishko, Kurt A. Swanson, et al.. (2022). Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle. npj Vaccines. 7(1). 74–74. 16 indexed citations

7.

Swanson, Kurt A., Michael Kishko, Vincent Pavot, et al.. (2020). A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain. Science Immunology. 5(47). 83 indexed citations

8.

Kishko, Michael, John Catalan, Kurt A. Swanson, et al.. (2020). Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model. Virology. 550. 21–26. 14 indexed citations

9.

Groppo, Rachel, Joshua M. DiNapoli, Michael Kishko, et al.. (2018). Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine. PLoS ONE. 13(6). e0199452–e0199452. 9 indexed citations

10.

Mundle, Sophia T., Michael Kishko, Rachel Groppo, et al.. (2016). Core bead chromatography for preparation of highly pure, infectious respiratory syncytial virus in the negative purification mode. Vaccine. 34(32). 3690–3696. 15 indexed citations

11.

Jeong, Kwang‐il, Peter Piepenhagen, Michael Kishko, et al.. (2015). CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner. PLoS ONE. 10(6). e0130517–e0130517. 85 indexed citations

12.

Wang, Shixia, Michael Kishko, Yan Wang, et al.. (2012). Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates. Human Vaccines & Immunotherapeutics. 8(11). 1638–1647. 2 indexed citations

13.

Kishko, Michael, Mohan Somasundaran, Frank Brewster, et al.. (2011). Genotypic and functional properties of early infant HIV-1 envelopes. Retrovirology. 8(1). 67–67. 26 indexed citations

14.

Sakhatskyy, Pavlo, Shixia Wang, Chuanyou Zhang, et al.. (2007). Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens. Virology. 371(1). 98–107. 32 indexed citations

15.

Barouch, Dan H., Jennifer Powers, Diana M. Truitt, et al.. (2005). Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nature Immunology. 6(3). 247–252. 50 indexed citations

16.

Barouch, Dan H., Zhi-Yong Yang, Wing-Pui Kong, et al.. (2005). A Human T-Cell Leukemia Virus Type 1 Regulatory Element Enhances the Immunogenicity of Human Immunodeficiency Virus Type 1 DNA Vaccines in Mice and Nonhuman Primates. Journal of Virology. 79(14). 8828–8834. 109 indexed citations

17.

Lynch, Diana M., Jaap Goudsmit, Angelique A. C. Lemckert, et al.. (2005). Immunogenicity of Recombinant Fiber-Chimeric Adenovirus Serotype 35 Vector-Based Vaccines in Mice and Rhesus Monkeys. Journal of Virology. 79(22). 14161–14168. 76 indexed citations

18.

Sumida, Shawn M., Paul F. McKay, Diana M. Truitt, et al.. (2004). Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. Journal of Clinical Investigation. 114(9). 1334–1342. 109 indexed citations

19.

Barouch, Dan H., Maria Grazia Pau, Jerome Custers, et al.. (2004). Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity. The Journal of Immunology. 172(10). 6290–6297. 313 indexed citations

20.

Sumida, Shawn M., Paul F. McKay, Diana M. Truitt, et al.. (2004). Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. Journal of Clinical Investigation. 114(9). 1334–1342. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact